Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
IMVT

Updated 10/6/2026, 10:27 AM ET.

IMVT

Immunovant, Inc.

Sale$119,590

Venker Eric

Chief Executive Officer, Director

3,506 shat $34.11Filed Oct 5, 7:42 PM ETFiling
IMVT

Immunovant, Inc.

Sale$103,481

Van Tuyl Christopher

Chief Legal Officer

2,846 shat $36.36Filed Sep 25, 4:05 PM ETFiling
IMVT

Immunovant, Inc.

Sale$64,905

Pande Atul

Director

1,500 shat $43.27Filed Aug 28, 4:27 PM ET
Filing
IMVT

Immunovant, Inc.

Sale$134,953

Gloria Melanie

Chief Operating Officer

3,056 shat $44.16Filed Aug 21, 4:03 PM ETFiling
IMVT

Immunovant, Inc.

Sale$59,700

Pande Atul

Director

1,500 shat $39.80Filed Jul 24, 5:59 PM ET
Filing
IMVT

Immunovant, Inc.

Sale$263,015

Girao Tiago

Chief Financial Officer

6,798 shat $38.69Filed Jul 24, 5:57 PM ETFiling
IMVT

Immunovant, Inc.

Sale$110,537

Stout Jay S

Chief Technology Officer

2,857 shat $38.69Filed Jul 24, 5:57 PM ETFiling
IMVT

Immunovant, Inc.

Sale$80,532

Gloria Melanie

Chief Operating Officer

2,036 shat $39.55Filed Jul 10, 4:15 PM ETFiling
IMVT

Immunovant, Inc.

Sale$47,702

Van Tuyl Christopher

Chief Legal Officer

1,206 shat $39.55Filed Jul 10, 4:13 PM ETFiling
IMVT

Immunovant, Inc.

Sale$137,925

Stout Jay S

Chief Technology Officer

3,487 shat $39.55Filed Jul 10, 4:12 PM ETFiling

Read from public SEC filings. Not financial advice.